Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
17.01
Dollar change
+0.98
Percentage change
6.11
%
IndexRUT P/E27.92 EPS (ttm)0.61 Insider Own15.29% Shs Outstand107.12M Perf Week21.15%
Market Cap2.00B Forward P/E10.53 EPS next Y1.61 Insider Trans-1.39% Shs Float99.84M Perf Month18.13%
Income71.41M PEG- EPS next Q0.20 Inst Own64.98% Short Float5.68% Perf Quarter21.07%
Sales398.20M P/S5.03 EPS this Y81.90% Inst Trans9.10% Short Ratio3.78 Perf Half Y17.80%
Book/sh3.62 P/B4.70 EPS next Y40.92% ROA16.82% Short Interest5.67M Perf Year10.03%
Cash/sh1.17 P/C14.57 EPS next 5Y- ROE20.75% 52W Range11.09 - 18.22 Perf YTD1.19%
Dividend Est.- P/FCF- EPS past 5Y- ROI18.26% 52W High-6.64% Beta0.93
Dividend TTM- Quick Ratio2.68 Sales past 5Y4106.79% Gross Margin78.77% 52W Low53.38% ATR (14)0.64
Dividend Ex-Date- Current Ratio2.88 EPS Y/Y TTM-16.14% Oper. Margin21.80% RSI (14)75.73 Volatility4.90% 3.55%
Employees167 Debt/Eq0.01 Sales Y/Y TTM85.90% Profit Margin17.93% Recom1.00 Target Price27.80
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q36.50% Payout0.00% Rel Volume2.45 Prev Close16.03
Sales Surprise3.00% EPS Surprise16.98% Sales Q/Q81.98% EarningsFeb 28 AMC Avg Volume1.50M Price17.01
SMA2022.24% SMA5015.25% SMA20025.84% Trades Volume3,673,644 Change6.11%
Date Action Analyst Rating Change Price Target Change
Dec-21-23Initiated Oppenheimer Outperform $30
Aug-24-22Downgrade ROTH Capital Buy → Neutral $10 → $15.50
Sep-21-18Initiated Cantor Fitzgerald Overweight
Sep-07-18Resumed Piper Jaffray Overweight
Oct-05-16Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16Downgrade Piper Jaffray Overweight → Neutral $6 → $1
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
Sep-15-14Reiterated H.C. Wainwright Buy $5 → $13
Oct-21-13Reiterated Aegis Capital Buy $4 → $5.50
Feb-29-24 12:10PM
Feb-28-24 07:20PM
06:35PM
06:03PM
Feb-27-24 08:03AM
09:00AM Loading…
Feb-21-24 09:00AM
Feb-14-24 08:03AM
Jan-18-24 09:50AM
04:54AM
Jan-15-24 08:45AM
Jan-14-24 08:40AM
Jan-12-24 09:45AM
Jan-09-24 04:57PM
04:05PM
Jan-08-24 08:55AM
08:02AM Loading…
Jan-05-24 08:02AM
Jan-04-24 04:49PM
Dec-18-23 06:30AM
Dec-17-23 12:03PM
Dec-08-23 11:30AM
Dec-05-23 08:03AM
Dec-04-23 08:03AM
Nov-16-23 08:05AM
Nov-09-23 06:10AM
Nov-08-23 04:11PM
Nov-02-23 10:37AM
10:00AM
Nov-01-23 10:01AM
Oct-30-23 08:03AM
Oct-26-23 03:19PM
08:03AM Loading…
Oct-23-23 08:03AM
Oct-19-23 08:03AM
Oct-16-23 08:03AM
Oct-13-23 08:03AM
Oct-12-23 09:50AM
09:40AM
Sep-18-23 08:03AM
Sep-08-23 11:30AM
Sep-06-23 01:06PM
Aug-16-23 10:56AM
Aug-14-23 08:05AM
Aug-11-23 06:09AM
Aug-09-23 05:50PM
04:41PM
04:17PM
Aug-03-23 02:44PM
Jul-25-23 08:03AM
Jul-24-23 08:03AM
Jul-23-23 10:21AM
Jul-19-23 06:00AM
Jul-05-23 05:50PM
Jul-02-23 01:46PM
Jun-29-23 05:50PM
Jun-23-23 05:50PM
Jun-21-23 08:00PM
Jun-20-23 06:00AM
Jun-19-23 09:30AM
Jun-14-23 05:50PM
Jun-09-23 11:30AM
Jun-01-23 09:30AM
08:03AM
May-30-23 08:03AM
May-22-23 08:15AM
May-12-23 09:30AM
May-11-23 08:41AM
May-10-23 05:55PM
04:53PM
04:27PM
May-09-23 08:03AM
May-03-23 05:45PM
May-01-23 08:03AM
Apr-27-23 05:45PM
Apr-26-23 08:00PM
12:45PM
Apr-24-23 05:50PM
08:03AM
Apr-20-23 12:26PM
08:03AM
Apr-18-23 05:50PM
Apr-14-23 11:30AM
05:05AM
Apr-12-23 05:50PM
Apr-11-23 09:45AM
Apr-07-23 07:30AM
Apr-05-23 10:15AM
Apr-04-23 05:50PM
10:23AM
Apr-03-23 12:45PM
09:00AM
Mar-27-23 05:50PM
07:12AM
Mar-22-23 09:55AM
Mar-21-23 05:50PM
09:00AM
Mar-17-23 09:30AM
Mar-16-23 12:45PM
Mar-15-23 05:25PM
04:11PM
Mar-13-23 06:30AM
Mar-10-23 09:00AM
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENKHAUS DONALD ADirectorFeb 05Option Exercise4.0140,000160,400434,333Feb 06 05:00 PM
MCENANY PATRICK JChairman of Board of DirectorsJan 02Option Exercise1.13250,000282,5004,385,256Jan 03 05:19 PM
O'Keeffe Charles BDirectorJan 02Option Exercise1.1360,00067,800681,724Jan 03 05:18 PM
Tierney David SDirectorJan 02Option Exercise1.1310,00011,300344,874Jan 03 05:19 PM
Harper MollyDirectorDec 15Option Exercise5.7810,00057,80010,000Dec 19 05:00 PM
Harper MollyDirectorDec 15Sale14.3914,000201,4200Dec 19 05:00 PM
Tierney David SDirectorDec 12Option Exercise1.1350,00056,500383,541Dec 14 05:00 PM
Tierney David SDirectorDec 12Sale13.3250,000666,250333,541Dec 14 05:00 PM
Miller SteveChief Op. & Scientific OfficerDec 11Option Exercise1.13150,000169,500797,457Dec 13 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 11Option Exercise1.1360,00067,800110,557Dec 12 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 11Sale13.7660,000825,78050,557Dec 12 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 08Option Exercise1.1340,00045,20090,557Dec 12 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 08Sale14.2840,000571,00050,557Dec 12 05:00 PM
Daly Richard JDirectorDec 07Option Exercise1.1360,00067,800208,000Dec 11 05:00 PM
INGENITO GARYChief Med. & Reg. OfficerDec 06Option Exercise1.1350,00056,50088,367Dec 08 05:00 PM
INGENITO GARYChief Med. & Reg. OfficerDec 06Sale14.0250,000701,00038,367Dec 08 05:00 PM
Miller SteveChief Op. & Scientific OfficerDec 05Sale14.2440,000569,600647,457Dec 07 05:00 PM
DENKHAUS DONALD ADirectorAug 03Option Exercise1.1360,00067,800393,000Aug 04 05:00 PM
MCENANY PATRICK JPresident and CEOMay 16Option Exercise0.79173,849137,3414,119,285May 17 05:04 PM
MCENANY PATRICK JPresident and CEOMay 15Option Exercise0.7926,15120,6593,971,587May 17 05:04 PM
MCENANY PATRICK JPresident and CEOMay 15Sale13.2326,151345,9783,945,436May 17 05:04 PM
Daly Richard JDirectorMay 12Option Exercise0.7950,00039,500148,000May 16 05:01 PM
Miller SteveChief Operating OfficerMay 11Option Exercise0.79100,00079,000687,457May 12 05:00 PM
Tierney David SDirectorMay 11Option Exercise0.7920,00015,800333,541May 12 05:01 PM
COELHO PHILIP HDirectorMay 04Option Exercise0.7950,00039,500204,887May 05 05:00 PM
Tierney David SDirectorApr 05Option Exercise0.7930,00023,700343,541Apr 07 05:00 PM
Tierney David SDirectorApr 05Sale16.8330,000504,900313,541Apr 07 05:00 PM
Del Carmen JeffreyChief Commercial OfficerMar 29Option Exercise3.1840,000127,06328,524Mar 30 05:01 PM
GRANDE ALICIAVP, Treasurer and CFOMar 29Option Exercise1.1350,00056,500100,557Mar 30 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 29Sale16.7050,000835,10050,557Mar 30 05:00 PM
Del Carmen JeffreyChief Commercial OfficerMar 29Sale16.7040,000667,8107,541Mar 30 05:01 PM
GRANDE ALICIAVP, Treasurer and CFOMar 28Option Exercise0.7958,21645,991108,773Mar 30 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 28Sale16.5458,216962,78650,557Mar 30 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 22Option Exercise0.7941,78433,00989,081Mar 24 05:00 PM
GRANDE ALICIAVP, Treasurer and CFOMar 22Sale16.5041,784689,52850,557Mar 24 05:00 PM
Elsbernd BrianChief Compliance/Legal OfficerMar 20Option Exercise1.1350,00056,500188,076Mar 22 04:45 PM
Elsbernd BrianChief Compliance/Legal OfficerMar 20Sale16.0750,000803,450138,076Mar 22 04:45 PM